Figure-1 (Tamsulosin Fig1)
Tamsulosin Hydrochloride
Product Images NDC 67296-1850
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 67296-1850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-2a (Tamsulosin Fig2a)
This is a chart that appears to be showing the mean change in treatment over the course of several weeks. The treatment options measured were 0.8mg, 0.4mg, and a placebo. The X-axis shows the duration of treatment in weeks and the Y-axis shows the mean change score. Additional details about the chart and its purpose are not available.*
Figure-2b (Tamsulosin Fig2b)
Tamsulosin-fig3a (Tamsulosin Fig3a)
Tamsulosin-fig3b (Tamsulosin Fig3b)
Tamsulosin-label (Tamsulosin Label)
Tamsulosin Hydrochloride Capsules are sold in 0.4mg capsules. The prescribed dose should be read with the included prescribing information. The medication should be kept out of reach of children and stored between 20° to 25°C (68° to 77°F), with brief excursions permitted between 15° and 30°C (59° and 86°F). Additional patient information is available at https://www.sunpharma.com/usa/products. The distributor is Sun Pharmaceutical Industries, Inc. and the manufacturer is Sun Pharmaceutical Industries Ltd. in Gujarat, India.*
Chemical-structure (Tamsulosin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
